Growth Metrics

Cross Country Healthcare (CCRN) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to -$0.15.

  • Cross Country Healthcare's EPS (Weighted Average and Diluted) fell 28750.0% to -$0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.49, marking a year-over-year decrease of 88000.0%. This contributed to the annual value of -$0.44 for FY2024, which is 12127.23% down from last year.
  • Latest data reveals that Cross Country Healthcare reported EPS (Weighted Average and Diluted) of -$0.15 as of Q3 2025, which was down 28750.0% from -$0.2 recorded in Q2 2025.
  • Cross Country Healthcare's 5-year EPS (Weighted Average and Diluted) high stood at $2.07 for Q4 2021, and its period low was -$0.47 during Q2 2024.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $0.51, with a median of $0.36 in 2023.
  • In the last 5 years, Cross Country Healthcare's EPS (Weighted Average and Diluted) skyrocketed by 165000.0% in 2021 and then crashed by 28750.0% in 2025.
  • Over the past 5 years, Cross Country Healthcare's EPS (Weighted Average and Diluted) (Quarter) stood at $2.07 in 2021, then tumbled by 53.37% to $0.97 in 2022, then tumbled by 73.12% to $0.26 in 2023, then tumbled by 143.24% to -$0.11 in 2024, then tumbled by 33.41% to -$0.15 in 2025.
  • Its last three reported values are -$0.15 in Q3 2025, -$0.2 for Q2 2025, and -$0.02 during Q1 2025.